Your browser doesn't support javascript.
loading
Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy.
Uribesalgo, Iris; Hoffmann, David; Zhang, Yin; Kavirayani, Anoop; Lazovic, Jelena; Berta, Judit; Novatchkova, Maria; Pai, Tsung-Pin; Wimmer, Reiner A; László, Viktória; Schramek, Daniel; Karim, Rezaul; Tortola, Luigi; Deswal, Sumit; Haas, Lisa; Zuber, Johannes; Szucs, Miklós; Kuba, Keiji; Dome, Balazs; Cao, Yihai; Haubner, Bernhard J; Penninger, Josef M.
Afiliación
  • Uribesalgo I; Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter, Vienna, Austria.
  • Hoffmann D; Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter, Vienna, Austria.
  • Zhang Y; Department of Microbiology, Tumor and Cell Biology, Biomedicum, Karolinska Institutet, Stockholm, Sweden.
  • Kavirayani A; Medicine and Pharmacy Research Center, Binzhou Medical University, Yantai, Shandong Province, China.
  • Lazovic J; VBCF Histopathology, Vienna BioCenter, Vienna, Austria.
  • Berta J; VBCF Preclinical Imaging, Vienna BioCenter, Vienna, Austria.
  • Novatchkova M; Department of Tumor Biology, National Koranyi Institute of Pulmonology, Budapest, Hungary.
  • Pai TP; Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter, Vienna, Austria.
  • Wimmer RA; Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter, Vienna, Austria.
  • László V; Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter, Vienna, Austria.
  • Schramek D; Division of Thoracic Surgery, Department of Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Karim R; Division of Molecular and Gender Imaging, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
  • Tortola L; Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter, Vienna, Austria.
  • Deswal S; Department of Molecular Genetics, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.
  • Haas L; Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter, Vienna, Austria.
  • Zuber J; Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter, Vienna, Austria.
  • Szucs M; Institute of Molecular Pathology (IMP), Vienna BioCenter, Vienna, Austria.
  • Kuba K; Institute of Molecular Pathology (IMP), Vienna BioCenter, Vienna, Austria.
  • Dome B; Institute of Molecular Pathology (IMP), Vienna BioCenter, Vienna, Austria.
  • Cao Y; Department of Urology, Semmelweis University, Budapest, Hungary.
  • Haubner BJ; Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter, Vienna, Austria.
  • Penninger JM; Department Biochemistry and Metabolic Science, Akita University Graduate School of Medicine, Akita, Japan.
EMBO Mol Med ; 11(8): e9266, 2019 08.
Article en En | MEDLINE | ID: mdl-31267692
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Movimiento Celular / Resistencia a Antineoplásicos / Inhibidores de la Angiogénesis / Inhibidores de Proteínas Quinasas / Apelina / Receptores de Apelina / Sunitinib / Neoplasias Pulmonares / Neoplasias Mamarias Experimentales / Neovascularización Patológica Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2019 Tipo del documento: Article País de afiliación: Austria Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Movimiento Celular / Resistencia a Antineoplásicos / Inhibidores de la Angiogénesis / Inhibidores de Proteínas Quinasas / Apelina / Receptores de Apelina / Sunitinib / Neoplasias Pulmonares / Neoplasias Mamarias Experimentales / Neovascularización Patológica Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2019 Tipo del documento: Article País de afiliación: Austria Pais de publicación: Reino Unido